Spoken Alpha
COLLEGIUM PHARMACEUTICAL, INC
Collegium Pharmaceutical designs and commercializes prescription medications for pain management and ADHD treatment in the United States.
COLLEGIUM PHARMACEUTICAL, INC is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $705.2M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for COLL.
$ curl https://api.spokenalpha.com/v1/companies/COLLFAQ
Spoken Alpha indexes COLL's earnings call transcripts at https://spokenalpha.com/companies/COLL. Each call links to attributed speakers and parsed analyst Q&A.
COLLEGIUM PHARMACEUTICAL, INC (COLL) held its most recent earnings call on 2026-08-06, covering fiscal Q2 2026.
COLLEGIUM PHARMACEUTICAL, INC (COLL) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $1.58 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $1.57 | $1.48 | +6.1% | $199.9M | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $1.76 | $1.52 | +15.8% | $193.5M | — | — | EODHD |
| Q4 FY2025 | 2026-02-25 | $1.85 | $2.01 | -8.0% | $205.4M | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $2.25 | $1.86 | +21.0% | $209.4M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $1.47 | $1.43 | +2.8% | $188.0M | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $1.49 | $1.45 | +2.8% | $177.8M | — | — | EODHD |
| Q4 FY2024 | 2025-02-19 | $1.77 | $1.54 | +15.1% | $181.9M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $1.61 | $1.59 | +1.3% | $159.3M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $1.62 | $1.49 | +8.7% | $145.3M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $1.45 | $1.47 | -1.4% | $144.9M | — | — | EODHD |
| Q4 FY2023 | 2024-02-21 | $1.58 | $1.25 | +26.4% | $149.7M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $1.34 | $1.24 | +8.1% | $136.7M | — | — | EODHD |
| Q2 FY2023 | 2023-08-02 | $1.26 | $1.22 | +3.3% | $135.5M | — | — | EODHD |
| Q1 FY2023 | 2023-05-03 | $1.32 | $1.51 | -12.6% | $144.8M | — | — | EODHD |
| Q4 FY2022 | 2023-02-22 | $-0.21 | $-0.14 | -50.0% | $129.6M | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $1.10 | $1.38 | -20.3% | $127.0M | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $1.21 | $1.44 | -16.0% | $123.5M | — | — | EODHD |
| Q1 FY2022 | 2022-05-09 | $0.91 | $0.90 | +1.1% | $83.8M | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $-0.51 | $1.04 | -100.0% | $27.4M | — | — | EODHD |
Source: EODHD. COLL reported actuals as published; sparse fields render as —.